Analysts split on whether Kenvue's (KVUE) reinvestment in Neutrogena could lead to market share gains. Read more here.

Fintel reports that on September 24, 2024, RBC Capital downgraded their outlook for Kenvue (NYSE:KVUE) from Outperform to ...

Fintel reports that on September 24, 2024, Jefferies initiated coverage of Kenvue (NYSE:KVUE) with a Buy recommendation. ...

Previously, Kenvue and Shenzhen Nepstar have been cooperating in the over-the-counter (OTC) drug field in China for many ...

RBC Capital Markets analysts downgraded Kenvue (NYSE: KVUE) stock on Tuesday, citing challenges in the company's Skin Health & Beauty segment, particularly with its Neutrogena bra ...

On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $23.02 which represents no change from the prior close of $23.02. The stock opened at $22.83 and touched a low of $22.76 ...

We suggest a new investor should avoid buying JNJ's stock now due to uncertainty surrounding its legal battles.

The French pharmaceutical company is likely to make a final decision on the unit in the coming days after reviewing the offers, Bloomberg said, citing people familiar to the matter. Both private ...

Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Kenvue Inc. (KVUE) ...

Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms ...

Between January 2021 and February 2022, the SEC alleged in a lawsuit filed Tuesday, Skael co-founder and CEO Baba Nadimpalli managed to raise more than $30 million from investors in the San ...

The Kroger Wellness Festival, a free, two-day event that celebrates healthy living, will bring many A-list celebrities to ...